121
|
|
|
BCL9 like |
B9L, BCL9-2, DLNB11 |
|
122
|
|
|
BCL2 associated transcription factor 1 |
BTF, bK211L9.1 |
|
123
|
|
|
Beta-carotene oxygenase 1 |
BCDO, BCDO1, BCMO, BCMO1, BCO |
|
124
|
|
|
Beta-carotene oxygenase 2 |
B-DIOX-II, BCDO2 |
|
125
|
|
|
BCL6 corepressor |
ANOP2, MAA2, MCOPS2 |
Brachycephaly, Adenoid cystic carcinoma, Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, Clear cell sarcoma of kidney, Congenital cataract, Dental caries, Kidney neoplasms, Microphthalmia, Osteosarcoma, Proliferative diabetic retinopathy, Retinitis pigmentosa, Rhabdomyosarcoma, Sarcoma, Wilms tumor |
126
|
|
|
BCL6 corepressor like 1 |
BCoR-L1, CXorf10, SHUVER |
|
127
|
|
|
BCR activator of RhoGEF and GTPase |
ALL, BCR1, CML, D22S11, D22S662, PHL |
Bipolar disorder, Blast crisis, B-lymphoblastic leukemia/lymphoma, Myelogenous leukemia, Myeloid leukemia, Melanoma, Chromosome 22q11.2 microdeletion syndrome, Lymphoblastic leukemia, Liver cirrhosis, Major depressive disorder, Myeloproliferative disorder, Necrosis, Skin disease, Depression |
128
|
|
|
BCS1 ubiquinol-cytochrome c reductase complex chaperone |
BCS, BCS1, BJS, FLNMS, GRACILE, Hs.6719, MC3DN1, PTD, h-BCS, h-BCS1 |
|
129
|
|
|
3-hydroxybutyrate dehydrogenase 1 |
BDH, SDR9C1 |
|
130
|
|
|
Bradykinin receptor B1 |
B1BKR, B1R, BKB1R, BKR1, BRADYB1 |
|